Bio-Techne (TECH) Equity Average (2010 - 2026)

Bio-Techne's Equity Average history runs 17 years deep, the most recent figure standing at $2.0 billion for Q1 2026.

• In Q1 2026, Equity Average changed 0.01% year-over-year to $2.0 billion; the TTM figure through Mar 2026 stood at $2.0 billion (changed 0.01% YoY), while the FY2025 annual figure was $2.0 billion, down 1.18% from the prior year.
• Equity Average was $2.0 billion for Q1 2026 at Bio-Techne, up from $2.0 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $2.1 billion in Q4 2024 to a low of $1.7 billion in Q2 2022.
• Historically, Equity Average has averaged $1.9 billion across 5 years, with a median of $2.0 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Equity Average increased 14.83% in 2023, then declined 7.67% in 2025.
• A 5-year view of Equity Average shows it stood at $1.8 billion in 2022, then increased by 10.7% to $2.0 billion in 2023, then increased by 6.46% to $2.1 billion in 2024, then decreased by 5.7% to $2.0 billion in 2025, then grew by 3.0% to $2.0 billion in 2026.
• The last three Equity Average figures came in at $2.0 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.